DII235

DII235 · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DII235, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DII235 in Adults With Elevated Lipoprotein(a) [Phase 2]